Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Harvard Business School
UBS
Medtronic
Mallinckrodt

Generated: June 27, 2019

DrugPatentWatch Database Preview

ALMOTRIPTAN MALATE Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which patents cover Almotriptan Malate, and what generic alternatives are available?

Almotriptan Malate is a drug marketed by Ajanta Pharma Ltd, Mylan, and Teva Pharms Usa. and is included in three NDAs.

The generic ingredient in ALMOTRIPTAN MALATE is almotriptan malate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.

Drug patent expirations by year for ALMOTRIPTAN MALATE
Synonyms for ALMOTRIPTAN MALATE
(zznon-labelled)Almotriptan-d6 Malate
1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine hydroxybutanedioate
1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedioate (1:1)
1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedionate (1:1)
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine malate
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine malate (1:1)
1-[[[2-(Dimethyl-amino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine Malate
1-[[[3-(2-dimethylamino)ethyl]-1H-indol-5-yl]-methyl]sulfonyl]pyrrolidine (+/-)-hydroxybutanedioate
1-[[3-(2-dimethylaminoethyl)-5-indolyl]methanesulphonyl]pyrrolidine Malate
181183-52-8
3-[2-(Dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl )-1H-indole malate
AB0011374
AB1004826
AC1L3WYS
AK110510
AKOS015950790
Almotriptan (malate)
Almotriptan malate (Axert)
Almotriptan malate (USAN)
Almotriptan malate [USAN]
Almotriptan Malate See
Almotriptan Malate(PNU180638)
Almotriptan MalateSee: A575201
Almotriptan maleate
AN-16757
API0000367
AS-12142
AX8113232
Axert (TN)
BCP05632
BCP9000276
Butanedioic acid, hydroxy-, compd. with 1-(((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine (1:1)
C21H31N3O7S
CHEBI:53781
CHEMBL1200521
CS-2455
D02825
DTXSID1044225
FT-0661519
HMS3651A12
HY-B0383
J-011571
KB-47261
KS-00000FM2
LAS 31416
LAS 31416 D,L-malate acid
LAS-31416 D,L-Malate acid
LAS-31416 Malate
LS-181812
MLS006010048
MolPort-006-391-878
N,N-dimethyl-2-(5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethan-1-amine 2-hydroxysuccinate
N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine; 2-hydroxybutanedioic acid
PNU 180638
PNU 180638E
PNU-180638E
QHATUKWEVNMHRY-UHFFFAOYSA-N
s2096
SCHEMBL221131
SMR004701216
SR-05000001986
SR-05000001986-2
ST24045938
SW219418-1
VA10091

US Patents and Regulatory Information for ALMOTRIPTAN MALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-001 Mar 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-002 Nov 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-002 Mar 3, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-001 Nov 9, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-002 Jul 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-001 Jul 7, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKesson
QuintilesIMS
UBS
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.